Source: Breathe, 15 (2) 137; 10.1183/20734735.0015-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lydia J. Finney. Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?. Breathe, 15 (2) 137; 10.1183/20734735.0015-2019

Member's Comments

No comment yet.

Related content which might interest you: The role of bronchodilator treatment in the prevention of exacerbations of COPD Source: Eur Respir J 2012; 40: 1545-1554 Year: 2012 Comparison of the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Is it effective to administer corticosteroids late for neonatal chronic lung disease? Source: Eur Respir J 2004; 24: Suppl. 48, 620s Year: 2004 Patients with underuse and overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhalation medication Source: International Congress 2017 – Inhalers and their use Year: 2017 Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016 Year: 2017 Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations Source: Eur Respir Rev 2006; 15: 47-51 Year: 2006 Is nebulized morphine effective in treating persistent dyspnea in very severe COPD? A preliminary report Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Predicting physician decision to prescribe systemic corticosteroids following an exacerbation of airways disease Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Opioid use, perhaps a harbinger of worsening COPD? Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Are bronchodilator drugs really useful in COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 94s Year: 2001 Is the coprescription of Beta-blockers and Beta2-agonists justified in patients with coexisting COPD and CHF? Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD Year: 2009 Reducing cholinergic constriction: the major reversible mechanism in COPD Source: Eur Respir Rev 2006; 15: 32-36 Year: 2006 Utility of palliative treatment of dyspnoea with epidural methadone in patients with advanced emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 58s Year: 2001 Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients Source: ERJ Open Res, 6 (3) 00093-2020; 10.1183/23120541.00093-2020 Year: 2020 Roflumilast with long-acting ?2-agonists for COPD: influence of exacerbation history Source: Eur Respir J 2011; 38: 553-560 Year: 2011 Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care Source: Annual Congress 2011 - Disease management in specific primary care populations Year: 2011 Modern treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 60S-66S Year: 2001 Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist Source: Annual Congress 2009 - Drug effects in COPD Year: 2009